Ozop Energy Solutions (OZSC) 10-Q 16 May 22 2022 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2022	May 10, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2022
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Entity File Number	000-55976
Entity Registrant Name	OZOP ENERGY SOLUTIONS, INC.
Entity Central Index Key	0001679817
Entity Tax Identification Number	35-2540672
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	42 N Main St
Entity Address, City or Town	Florida
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10921
City Area Code	(845)
Local Phone Number	544-5112
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		4,622,362,977

Condensed Consolidated Balance

Condensed Consolidated Balance Sheet (Unaudited) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current Assets
Cash	$ 3,636,662	$ 6,767,167
Prepaid expenses	169,412	151,998
Accounts receivable	1,285,612	1,299,334
Inventory	2,336,605	1,065,982
Vendor deposits	1,469,991	874,627
Total Current Assets	8,898,282	10,159,108
Operating lease right-of-use asset, net	657,339	707,686
Property and equipment, net	160,705	132,889
Other Assets	567,000	568,249
TOTAL ASSETS	10,283,326	11,567,932
Current Liabilities
Accounts payable and accrued expenses	3,824,854	3,246,342
Convertible notes payable, net of discounts	25,000	25,000
Current portion of notes payable, net of discounts	16,390,428	13,011,307
Customer deposits	593,034	169,849
Deferred liability	750,000	750,000
Derivative liabilities	16,601,498	20,966,701
Operating lease liability, current portion	177,858	194,366
Current portion of deferred revenues	21,451	21,451
Total Current Liabilities	38,384,123	38,385,016
Long Term Liabilities
Note payable, net of discount	389,423	389,423
Operating lease liability, net of current portion	486,008	517,890
Deferred revenue, net of current portion	19,664	25,026
TOTAL LIABILITIES	39,279,218	39,317,355
Stockholders’ Equity (Deficit)
Series E Preferred Stock (3,000 shares authorized, -0- issued and outstanding, par value $0.001)
Common stock (4,990,000,000 shares authorized par value $0.001; 4,622,362,977 (2022) and 4,617,362,977 (2021) shares issued and outstanding)	4,622,363	4,617,363
Common stock to be issued; 637,755 shares as of March 31, 2022, and December 31, 2021	638	638
Additional paid in capital	196,594,222	196,464,222
Treasury Stock	(11,249,934)	(11,249,934)
Accumulated Deficit	(218,520,372)	(217,326,611)
Total Ozop Energy Systems, Inc. stockholders’ equity (deficit)	(28,553,079)	(27,494,318)
Noncontrolling interest	(442,813)	(255,105)
TOTAL STOCKHOLDERS’ EQUITY (DEFICIT)	(28,995,892)	(27,749,423)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)	10,283,326	11,567,932
Series C Preferred Stock [Member]
Stockholders’ Equity (Deficit)
Series E Preferred Stock (3,000 shares authorized, -0- issued and outstanding, par value $0.001)	3	3
Series D Preferred Stock [Member]
Stockholders’ Equity (Deficit)
Series E Preferred Stock (3,000 shares authorized, -0- issued and outstanding, par value $0.001)	1	1
Series E Preferred Stock [Member]
Stockholders’ Equity (Deficit)
Series E Preferred Stock (3,000 shares authorized, -0- issued and outstanding, par value $0.001)

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheet (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2022	Dec. 31, 2021
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	4,990,000,000	4,990,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares issued	4,622,362,977	4,617,362,977
Common stock, shares outstanding	4,622,362,977	4,617,362,977
Common stock to be issued	637,755	637,755
Series C Preferred Stock [Member]
Preferred stock, shares authorized	50,000	50,000
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares issued	2,500	2,500
Preferred stock, shares outstanding	2,500	2,500
Series D Preferred Stock [Member]
Preferred stock, shares authorized	4,570	4,570
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares issued	1,334	1,334
Preferred stock, shares outstanding	1,334	1,334
Series E Preferred Stock [Member]
Preferred stock, shares authorized	3,000	3,000
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0

Condensed Consolidated Statemen

Condensed Consolidated Statement of Comprehensive Income (Loss) (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Revenue	$ 3,082,238	$ 795,554
Cost of goods sold	2,875,832	226,909
Gross profit	206,406	568,645
Operating expenses:
General and administrative, related parties	390,000	2,115,008
General and administrative, other	1,587,857	3,674,462
Total operating expenses	1,977,857	5,789,470
Loss from operations	(1,771,451)	(5,220,825)
Other (income) expenses:
Interest expense	3,975,221	40,654,750
(Gain) loss on change in fair value of derivatives	(4,365,203)	52,197,902
Loss on extinguishment of debt		94,968,891
Debt restructure expense		16,450,000
Total Other (Income) Expenses	(389,982)	204,271,543
Loss before income taxes	(1,381,469)	(209,492,368)
Income tax provision
Net Loss	(1,381,469)	(209,492,368)
Less: net loss attributable to noncontrolling interest	(187,708)
Net loss attributable to Ozop Energy Solutions, Inc.	$ (1,193,761)	$ (209,492,368)
Loss per share basic and fully diluted	$ 0	$ (0.05)
Weighted average shares outstanding
Basic and diluted	4,619,807,422	3,978,009,658

Condensed Consolidated Statem_2

Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Common Stock To Be Issued [Member]	Preferred Stock [Member]Series C Preferred Stock [Member]	Preferred Stock [Member]Series D Preferred Stock [Member]	Preferred Stock [Member]Series E Preferred Stock [Member]	Common Stock [Member]	Treasury Stock [Member]	AOCI Attributable to Parent [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]	Total
Beginning balance, value at Dec. 31, 2020		$ 50	$ 20	$ 1	$ 3,397,958		$ (7)	$ 12,530,933	$ (22,278,665)		$ (6,349,710)
Balance, share at Dec. 31, 2020		50,000	20,000	1,000	3,397,958,292
Shares issued and to be issued for fees and services	$ 5,000				$ 20,000			2,877,000			2,902,000
Shares issued and to be issued for fees and services, shares	5,000,000				20,000,000
Net loss							7		(209,492,368)		(209,492,368)
Shares issued for conversions of note and interest payable					$ 428,748			97,110,282			97,539,030
Shares issued for conversions of note and interest payable, shares					428,747,654
Shares issued upon cashless exercise of warrants					$ 330,798			38,714,266			39,045,064
Shares issued upon cashless exercise of warrants, shares					330,797,987
Issuance of Series E Preferred Stock				$ 2				1,999,998			2,000,000
Issuance of Series E Preferred Stock, shares				2,000
Redemption of Series E Preferred Stock				$ (3)				(2,999,997)			(3,000,000)
Redemption of Series E Preferred Stock, shares				(3,000)
Shares issued for lease agreement					$ 100,000			530,000			630,000
Shares issued for lease agreement, shares					100,000,000
Shares issue for debt restructure					$ 175,000			16,275,000			16,450,000
Shares issued for debt restructure, shares					175,000,000
Ending balance, value at Mar. 31, 2021	$ 5,000	$ 50	$ 20		$ 4,452,504			167,037,482	(231,771,033)		(60,275,984)
Balance, shares at Mar. 31, 2021	5,000,000	50,000	20,000		4,452,503,933
Beginning balance, value at Dec. 31, 2021	$ 638	$ 3	$ 1		$ 4,617,363	$ (11,249,934)		196,464,222	(217,326,611)	$ (255,105)	(27,749,423)
Balance, share at Dec. 31, 2021	637,755	2,500	1,334		4,617,362,977
Shares issued and to be issued for fees and services					$ 5,000			130,000			135,000
Shares issued and to be issued for fees and services, shares					5,000,000
Net loss									(1,193,761)	(187,708)	(1,381,469)
Ending balance, value at Mar. 31, 2022	$ 638	$ 3	$ 1		$ 4,622,363	$ (11,249,934)		$ 196,594,222	$ (218,520,372)	$ (442,813)	$ (28,995,892)
Balance, shares at Mar. 31, 2022	637,755	2,500	1,334		4,622,362,977

Condensed Consolidated Statem_3

Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net loss from continuing operations	$ (1,381,469)	$ (209,492,368)
Adjustments to reconcile net loss to net cash used in operations
Non-cash interest expense	3,379,121	40,414,627
Amortization and depreciation	62,532	8,327
Debt restructure expense		16,450,000
(Gain) loss on fair value change of derivatives	(4,365,203)	52,197,902
Loss on extinguishment of debt		94,968,892
Stock compensation expense	136,249	4,902,000
Changes in operating assets and liabilities:
Accounts receivable	13,722	(430,367)
Inventory	(1,270,623)	108,664
Prepaid expenses	(17,415)	(111,799)
Vendor deposits	(595,364)
Accounts payable and accrued expenses	578,513	208,302
Deferred revenue	(5,363)
Operating lease liabilities	(48,390)	(1,788)
Customer deposits	423,185	(188,518)
Net cash used in operating activities	(3,090,504)	(966,126)
Cash flows from investing activities:
Purchase of office and computer equipment	(40,000)	(35,306)
Net cash used in investing activities	(40,000)	(35,306)
Cash flows from financing activities:
Proceeds from issuances of notes payable		12,000,000
Payments to shareholders		(11,591)
Payments of principal of convertible note payable and notes payable		(3,089)
Redemption of Series E Preferred Stock		(3,000,000)
Net cash provided by financing activities		8,985,320
Net (decrease) increase in cash	(3,130,504)	7,983,888
Cash, Beginning of period	6,767,167	1,808,476
Cash, End of period	3,636,663	9,792,364
Supplemental disclosure of cash flow information:
Cash paid for interest	10,075	16,523
Cash paid for income taxes
Schedule of non-cash Investing or Financing Activity:
Original issue discount included in notes payable		1,310,000
Issuance of common stock upon convertible note and accrued interest conversion		658,245
Issuance of common stock and preferred stock for consulting fees and compensation	136,249	4,902,000
Issuance of common stock for lease agreement		630,000
Issuance of common stock for debt restructuring		$ 16,450,000

ORGANIZATION

ORGANIZATION	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION	NOTE 1 - ORGANIZATION Business Ozop Energy Solutions, Inc. (the” Company,” “we,” “us” or “our”) was originally incorporated as Newmarkt Corp. on July 17, 2015, under the laws of the State of Nevada. On October 29, 2020, the Company formed a new wholly owned subsidiary, Ozop Surgical Name Change Subsidiary, Inc., a Nevada corporation (“Merger Sub”). The Merger Sub was formed under the Nevada Revised Statutes for the sole purpose and effect of changing the Company’s name to “Ozop Energy Solutions, Inc.” That same day the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with the Merger Sub and filed Articles of Merger (the “Articles of Merger”) with the Nevada Secretary of State, merging the Merger Sub into the Company, which were stamped effective as of November 3, 2020. As permitted by the Section 92.A.180 of the Nevada Revised Statutes, the sole purpose and effect of the filing of Articles of Merger was to change the name of the Company from Ozop Surgical Corp to “Ozop Energy Solutions, Inc.” On December 11, 2020, the Company formed Ozop Energy Systems, Inc. (“OES”), a Nevada corporation and a wholly owned subsidiary of the Company. OES was formed to be a manufacturer and distributor of renewable energy products. On August 19, 2021, the Company formed Ozop Capital Partners, Inc. (“Ozop Capital”), a Delaware corporation. The Company is the majority shareholder of Ozop Capital with PJN Holdings LLC (“PJN”), a New York limited liability company, being the minority shareholder. Brian Conway was appointed as the sole officer and director of Ozop Capital and has voting control of Ozop Capital. On October 29, 2021, EV Insurance Company, Inc. (“EVCO”) was formed as a captive insurance company in the State of Delaware. EVCO is a wholly owned subsidiary of Ozop Capital. On January 7, 2022, EVCO filed with New Castle County, Delaware DBA OZOP Plus. On February 25, 2022, the Company formed Ozop Engineering and Design, Inc. (“OED”) a Nevada corporation, as a wholly owned subsidiary of the Company. OED was formed to become a premier engineering and lighting control design firm. OED offers product and design support for lighting and solar projects with a focus on fast lead times and technical support. OED and our partners are able to offer the resources needed for lighting, solar and electrical design projects. OED will provide customers systems to coordinate the understanding of electrical usage with the relationship between lighting design and lighting controls, by developing more efficient ecofriendly designs. We work with architects, engineers, facility managers, electrical contractors and engineers.

GOING CONCERN AND MANAGEMENT_S

GOING CONCERN AND MANAGEMENT’S PLANS	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN AND MANAGEMENT’S PLANS	NOTE 2 – GOING CONCERN AND MANAGEMENT’S PLANS The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of March 31, 2022, the Company had an accumulated deficit of $ 218,520,372 29,485,841 16,601,498 15,369,247 In December 2019, a novel strain of coronavirus (COVID-19) emerged. Because COVID-19 infections have been reported throughout the United States, certain federal, state and local governmental authorities have issued stay-at-home orders, proclamations and/or directives aimed at minimizing the spread of COVID-19. The ultimate impact of the COVID-19 pandemic on the Company’s operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but it may have a material adverse impact on our business, financial condition and results of operations. Management expects that its business will be impacted to some degree, but the significance of the impact of the COVID-19 outbreak on the Company’s business and the duration for which it may have an impact cannot be determined at this time. Management’s Plans As a public company, Management believes it will be able to access the public equities market for fund raising for product development, sales and marketing and inventory requirements as we expand our distribution in the U.S. market. On October 14, 2021, the Company received a Notice of effectiveness related to the Company’s Form S-3 Registration Statement (the “Registration Statement”). Pursuant to the Registration Statement the Company may offer and sell from time to time in one or more offerings of up to thirty million dollars ($ 30,000,000 On April 4, 2022, the Company and GHS Investments LLC (“GHS”). signed a Securities Purchase Agreement (the “GHS Purchase Agreement”) for the sale of up to Two Hundred Million ( 200,000,000 October 4, 2022 The purchase price shall be 85% of lowest VWAP for the ten (10) days preceding the Company’s notice to GHS for the sale of the Company’s common stock. On April 8, 2022, the Company filed a Prospectus Supplement to the Registration Statement dated October 14, 2021, regarding the GHS Purchase Agreement The Company is in negotiations with its’ lenders related to the debt instruments that are currently in default, to extend the maturity dates. OES is actively engaged in the renewable, electric vehicle (“EV”), energy storage and energy resiliency sectors. We are engaged in multiple business lines that include project development as well as equipment distribution. Our solar and energy storage projects involve large-scale battery and solar photovoltaics (PV) installations. Our utility-scale storage business model is based on an arbitrage business model in which we install multiple 1+ megawatt batteries, charge them with off-peak grid electricity under contract with the utility, then sell the power back during peak load hours at a premium, as dictated by prevailing electricity tariffs.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING PRONOUNCEMENTS	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING PRONOUNCEMENTS	NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING PRONOUNCEMENTS Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of March 31, 2022, and the results of operations and cash flows for the periods presented. The results of operations for the three months ended March 31, 2022, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in the Company’s Current Report on Form 10-K/A filed on April 26, 2022. The unaudited condensed consolidated financial statements include the accounts of the Company and Ozop Energy Systems, Inc. and the Company’s other wholly owned subsidiaries PCTI, Ozop LLC, Ozop HK and Spinus, LLC (“Spinus”) and the Company’s majority owned subsidiary Ozop Capital Partners, Inc. All intercompany accounts and transactions have been eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value. Cash and cash equivalent balances may, at certain times, exceed federally insured limits. The Company has no cash equivalents at March 31, 2022, and December 31, 2021. Sales Concentration and credit risk Following is a summary of customers who accounted for more than ten percent (10%) of the Company’s revenues for the three months ended March 31, 2022, and 2021, and their accounts receivable balance as of March 31, 2022: SCHEDULES OF CONCENTRATION OF RISK, BY RISK FACTOR Sales % Sales % Accounts Customer A 18.5 % N/A $ 420,390 Customer B 14.7 % N/A 308,345 Customer C 14.5 % N/A - Customer D 13.5 % N/A 3,835 Customer E N/A 95 % - Accounts Receivable The Company records accounts receivable at the time products and services are delivered. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience. Inventory Inventories are valued at the lower of cost or net realizable value, with cost determined on the first-in, first-out basis. Inventory costs include finished goods, material, labor and manufacturing overhead. In evaluating the net realizable value of inventory, management also considers, if applicable, other factors, including known trends, market conditions, currency exchange rates and other such issues. The components of inventories at March 31, 2022, and December 31, 2021, are as follows: SCHEDULE OF INVENTORY March 31, December 31, Raw materials $ 236,959 $ 234,168 Work in process 58,202 43,704 Finished goods 2,041,444 788,110 Inventory net $ 2,336,605 $ 1,065,982 Purchase concentration OES purchases finished renewable energy products from its’ suppliers. For the three months ended March 31, 2022, there were four suppliers that accounted for 35.7% 24.1% 12.6% 10.1% 20% The principal purchases by PCTI are comprised of parts and raw materials that PCTI assembles and manufactures and sells to its customers. There were no suppliers who accounted for more than ten percent (10%) of the Company’s purchases for the three months ended March 31, 2021. Property, plant and equipment Property and equipment are stated at cost, and depreciation is provided by use of a straight-line method over the estimated useful lives of the assets. The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable. The estimated useful lives of property and equipment is as follows: SCHEDULE OF USEFUL LIFE OF PROPERTY AND EQUIPMENT ASSETS Office furniture and equipment 3 5 Warehouse equipment 7 Revenue Recognition The Company recognizes revenue in accordance with ASC 606, from the commercial sales of products by: (1) identify the contract (if any) with a customer; (2) identify the performance obligations in the contract (if any); (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract (if any); and (5) recognize revenue when each performance obligation is satisfied. Under ASC 606, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. Other than The Company has no outstanding contracts with any of its’ customers. The Company recognizes revenue when title, ownership, and risk of loss pass to the customer, all of which occurs upon shipment or delivery of the product and is based on the applicable shipping terms. For contracts with customers, ownership of the goods and associated revenue are transferred to customers at a point in time, generally upon shipment of a product to the customer or receipt of the product by the customer and without significant judgments. Advance payments are typically required for commercial customers and are recorded as current liability until revenue is recognized. Advance payments are not required for government customers. The majority of contracts typically require payment within 30 to 60 days after transfer of ownership to the customer. For the periods covered herein, we did not have post shipment obligations such as training or installation, customer acceptance provisions, credits and discounts, rebates and price protection, or other similar privileges. The following table disaggregates our revenue by major source for the three months ended March 31, 2022 and 2021: DISAGGREGATION OF REVENUE Three months ended Three months ended Sourced and distributed products $ 2,919,322 $ - Manufactured products 162,916 795,554 Total $ 3,082,238 $ 795,554 Revenues from sourced and distributed products are purchased from suppliers as finished goods and the Company brings the finished goods into our California warehouse to fill orders as well as to build inventory for future sales orders. From time to time for some of our larger orders we may have our suppliers ship directly to our customers to avoid extra shipping charges. For manufactured products, there is usually a bidding process by branches of the military or other large firms that need mostly battery charging and storage systems for large industrial projects. We would then purchase the raw materials and parts needed to build out the project in our Pennsylvania warehouse. Advertising and Marketing Expenses The Company expenses advertising and marketing costs as incurred. For the three months ended March 31, 2022, and 2021, the Company recorded advertising and marketing expenses of $ 3,263 22,590 Research and Development Costs and expenses that can be clearly identified as research and development are charged to expense as incurred. For the three months ended March 31, 2022, and 2021, the Company did not record any research and development expenses. Convertible Instruments The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities. Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of this note transaction and the effective conversion price embedded in this note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption. The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt and equity linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities. Fair Value of Financial Instruments The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level. The following are the hierarchical levels of inputs to measure fair value: ● Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities. ● Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means. ● Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available. From time to time, certain of the Company’s embedded conversion features on debt and outstanding warrants have been treated as derivative liabilities for accounting purposes under ASC 815 due to insufficient authorized shares to fully settle conversion features of the instruments if exercised. In this case, the Company utilized the latest inception date sequencing method to reclassify outstanding instruments as derivative instruments. These contracts were recognized at fair value with changes in fair value recognized in earnings until such time as the conditions giving rise to such derivative liability classification were settled. The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable and accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments. The following table represents the Company’s derivative instruments that are measured at fair value on a recurring basis as of March 31, 2022, and December 31, 2021, for each fair value hierarchy level: SCHEDULE OF DERIVATIVE INSTRUMENTS March 31, 2022 Derivative Total Level I $ - $ - Level II $ - $ - Level III $ 16,601,498 $ 16,601,498 December 31, 2021 Derivative Total Level I $ - $ - Level II $ - $ - Level III $ 20,966,701 $ 20,966,701 Leases The Company accounts for leases under ASU 2016-02 (see Note 14), applying the package of practical expedients to leases that commenced before the effective date whereby the Company elected to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. For contracts entered into on or after the effective date, at the inception of a contract the Company assess whether the contract is, or contains, a lease. Our assessment is based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use of the asset throughout the period, and (3) whether we have the right to direct the use of the asset. We allocate the consideration in the contract to each lease component based on its relative stand-alone price to determine the lease payments. Operating lease ROU assets represent the right to use the leased asset for the lease term and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit rate, the Company used an incremental borrowing rate of 7.5%, for the existing lease, based on the information available at the adoption date in determining the present value of future payments. Operating lease expense is recognized pursuant to on a straight-line basis over the lease term and is included in rent in the condensed consolidated statements of operations. Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance on deferred tax assets is established when management considers it is more likely than not that some portion or all of the deferred tax assets will not be realized. Tax benefits from an uncertain tax position are only recognized if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting periods presented Segment Policy The Company has no reportable segments as it operates in one segment; renewable energy. Earnings (Loss) Per Share The Company reports earnings (loss) per share in accordance with ASC 260, “Earnings per Share.” Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during each period. Diluted earnings per share is computed by dividing net loss by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. As of March 31, 2022, and 2021, the Company’s dilutive securities are convertible into approximately 7,689,322,026 14,215,032,540 SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE March 31, 2022 March 31, 2021 Convertible preferred stock (1) 6,933,544,491 13,357,511,800 Unexercised common stock purchase warrants (1) 672,024,518 707,950,819 Convertible notes payable 2,461,916 144,569,921 Promissory note payable (1) 81,291,096 Common stock to be issued - 5,000,000 7,689,322,026 14,215,032,540 (1) The potentially dilutive shares included in the above table are limited whereby the conversion or exercise cannot result in the beneficial owner holding more than 4.99 Recent Accounting Pronouncements In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging —Contracts in Entity’ Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’ Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company does not believe the adoption of the ASU will have a material impact on the Company’s financial position, results of operations or cash flows. Other than the above, there have no recent accounting pronouncements or changes in accounting pronouncements during the period ended March 31, 2022, that are of significance or potential significance to the Company.

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	3 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT	NOTE 4 – PROPERTY AND EQUIPMENT The following table summarizes the Company’s property and equipment: PROPERTY AND EQUIPMENT March 31, 2022 December 31, 2021 Office equipment $ 300,083 $ 260,083 Less: Accumulated Depreciation (139,378 ) (127,194 ) Property and Equipment, Net $ 160,705 $ 132,889 Depreciation expense was $ 12,184 8,328

CONVERTIBLE NOTES PAYABLE

CONVERTIBLE NOTES PAYABLE	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
CONVERTIBLE NOTES PAYABLE	NOTE 5 - CONVERTIBLE NOTES PAYABLE On July 10, 2020, PCTI (the accounting acquirer) assumed the balance of a past-due 15% convertible note issued by the Company on September 13, 2017. As of March 31, 2022, and December 31, 2021, the outstanding principal balance of this note was $ 25,000

DERIVATIVE LIABILITIES

DERIVATIVE LIABILITIES	3 Months Ended
	Mar. 31, 2022
Derivative Liabilities
DERIVATIVE LIABILITIES	NOTE 6 – DERIVATIVE LIABILITIES The Company determined the conversion feature of the convertible notes, which all contain variable conversion rates, represented an embedded derivative since the notes were convertible into a variable number of shares upon conversion. Accordingly, the notes are not considered to be conventional debt under ASC 815 and the embedded conversion feature was bifurcated from the debt host and accounted for as a derivative liability. At any given time, certain of the Company’s embedded conversion features on debt and outstanding warrants may be treated as derivative liabilities for accounting purposes under ASC 815-40 due to insufficient authorized shares to settle these outstanding contracts. Pursuant to SEC staff guidance that permits a sequencing approach based on the use of ASC 815-15-25 which provides guidance for contracts that permit partial net share settlement. The sequencing approach may be applied in one of two ways: contracts may be evaluated based on (1) earliest issuance date or (2) latest maturity date. Pursuant to the sequencing approach, the Company evaluates its contracts based upon the latest maturity date. The Company valued the derivative liabilities at March 31, 2022, and December 31, 2021, at $ 16,601,498 20,966,701 1.06 0.19 83 92 2.08 2.39 48 .99 226 331 344 366 0.006 0.15 A summary of the activity related to derivative liabilities for the three months ended March 31, 2022, is as follows: SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE Derivative liabilities associated with warrants Derivative liabilities associated with convertible notes Total derivative liabilities Balance December 31, 2021 $ 20,938,755 $ 27,946 $ 20,966,701 Change in fair value (4,365,194 ) (9 ) (4,365,203 ) Balance March 31, 2022 $ 16,573,561 $ 27,937 $ 16,601,498

NOTES PAYABLE

NOTES PAYABLE	3 Months Ended
	Mar. 31, 2022
Notes Payable
NOTES PAYABLE	NOTE 7 – NOTES PAYABLE The Company has the following note payables outstanding: SCHEDULE OF NOTES PAYABLE March 31, 2022 December 31, 2021 $ 134,681 $ 134,681 Note payable bank, interest at 7.75 December 5, 2021 $ 134,681 $ 134,681 Note payable bank, interest at 6.5 December 26, 2021 344,166 344,166 Economic Injury Disaster Loan 10,000 10,000 Paycheck Protection Program loan 100,400 100,400 Notes payable, interest at 8 January 5, 2020 45,000 45,000 Other, due on demand, interest at 6 50,000 50,000 Note payable $ 750,000 12 August 24, 2021 375,000 375,000 Note payable $ 389,423 18 November 6, 2023 389,423 389,423 Note payable $ 1,000,000 12 November 13, 2021 1,000,000 1,000,000 Note payable $ 2,200,000 12 February 9, 2022 243,833 2,200,000 1,956,167 Note payable $ 11,110,000 12 March 17, 2022 2,314,583 11,110,000 8,795,417 Note payable $ 3,300,000 12 December 7, 2022 2,278,820 3,099,524 1,021,180 200,476 Sub- total notes payable 16,779,851 13,400,730 Less long-term portion 389,423 389,423 Current portion of notes payable, net of discount $ 16,390,428 $ 13,011,307 On December 7, 2021, the Company entered into a 12% 3,300,000 December 7, 2022 3,300,000 300,000 3,000,000 75,000,000 0.039 75,000 2,982,815 2,982,815 745,704 3,300,000 1,021,180 200,476 2,278,820 3,099,524 On March 17, 2021, the Company entered into a 12 11,110,000 March 17, 2022 11,110,000 1,000,000 110,000 10,000,000 250,000,000 0.13 231,250 33,248,433 10,000,000 23,248,433 32,248,433 2,083,333 11,110,000 11,100,000 8,795,417 2,314,583 1,362,421 1,033,687 On February 9, 2021, the Company entered into a 12 2,200,000 February 9, 2022 2,200,000 200,000 2,000,000 50,000,000 0.15 22,167 17,659,506 2,000,000 15,659,506 17,659,506 221,667 2,200,000 1,956,167 243,833 295,825 230,729 On November 13, 2020, the Company entered into a 12 1,000,000 November 13, 2021 Principal payments shall be made in six instalments of $166,667 commencing 180 days from the issue date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the maturity date 890,000 110,000 125,000,000 0.008 five 1,000,000 194,630 135,452 On November 6, 2020, the Company entered into a Settlement Agreement with the holder of $ 120,000 8,716 210,000 15,707 12 389,423 November 6, 2023 60,000,000 0.0075 five On October 26, 2016, PCTI entered into a $ 210,000 7.75 134,681 151,469 On March 15, 2021, PCTI renewed their $ 350,000 350,000 December 26, 2021 3.25 6.5 344,166 345,211 On August 24, 2020 (the “Issue Date”), the Company entered into a 12 750,000 Principal payments shall be made in six instalments of $125,000 commencing 180 days from the Issue Date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the Maturity Date. The Holder shall have the right from time to time, and at any time following an event of default, as defined on the agreement, to convert all or any part of the outstanding and unpaid principal, interest and any other amounts due into fully paid and non-assessable shares of common stock of the Company, at the lower of i) the Trading Price (as defined in the agreement) during the previous five trading days prior to the Issuance Date or ii) the volume weighted average price during the five trading days ending on the day preceding the conversion date 663,000 87,000 56,188 122,950,819 0.0061 750,000 375,000 75,000,000 375,000 112,747 90,247 On April 20, 2020, PCTI was granted a loan from Huntington Bank in the amount of $ 100,400 April 20, 2022 1.0 100,400 On July 14, 2020, PCTI received $ 10,000 10,000 The first payment due is deferred one year. The loan balance of March 31, 2022, and December 31, 2021 was $10,000 and has been classified in notes payable

DEFERRED LIABILITY

DEFERRED LIABILITY	3 Months Ended
	Mar. 31, 2022
Deferred Liability
DEFERRED LIABILITY	NOTE 8 – DEFERRED LIABILITY On September 2, 2020, PCTI entered into an agreement with a third- party. Pursuant to the terms of the agreement, in exchange for $ 750,000 3 750,000 175,000,000 1.8 0.094 16,450,000

DEFERRED REVENUE

DEFERRED REVENUE	3 Months Ended
	Mar. 31, 2022
Revenue from Contract with Customer [Abstract]
DEFERRED REVENUE	NOTE 9 – DEFERRED REVENUE During the year ended December 31, 2020, the Company received $ 64,353 payment of a three- year extended warranty 5,363 41,115 21,451 19,664 21,451 25,026

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended
	Mar. 31, 2022
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 10 – RELATED PARTY TRANSACTIONS Employment Agreement On July 10, 2020, pursuant to the PCTI transaction, the Company assumed an employment contract entered into on February 28, 2020, between the Company and Mr. Conway (the “Employment Agreement”). Mr. Conway’s compensation as adjusted was $ 20,000 10,000 Effective January 1, 2022, the Company entered into a new employment agreement with Mr. Conway. Pursuant to the agreement, Mr. Conway received a $ 250,000 240,000 20,000 20,000 Series E Preferred Stock On March 21, 2021, the Company issued 2,000 1,800 1,000 1,800,000 1,800 1,800,000 2,000 1,050 Management Fees and related party payables For the three months ended March 31, 2022, and 2021, the Company recorded expenses to its officers in the following amounts: SCHEDULE OF EXPENSES TO OFFICERS 2021 2020 Three months ended 2022 2021 CEO, parent $ 390,000 $ 279,999 CEO, parent- Series E Preferred Stock - 1,800,000 President, subsidiary (resigned July 2021) - 35,009 Total $ 125,583 $ 2,115,008 Redemption of Series C and Series D Preferred Stock On July 13, 2021, the Company entered into a Definitive Agreement (the “Agreement”) with Chis to purchase the 47,500 18,667 11,250,000

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 11 – COMMITMENTS AND CONTINGENCIES Leases On January 2, 2021, the Company entered into a ten ( 10 2,500 100,000,000 0.0063 630,000 Agreements On September 1, 2021, Ozop Capital entered into an advisory agreement (the “RMA Agreement”) with Risk Management Advisors, Inc. (“RMA”). Pursuant to the terms of the RMA Agreement, RMA will assist Ozop Capital in analyzing, structuring, and coordinating Ozop Capital’s participation in a captive insurance company. RMA will coordinate legal, accounting, tax, actuarial and other services necessary to implement the Company’s participation in a captive insurance company, including, but not limited to, the preparation of an actuarial feasibility study, filing of all required regulatory applications, domicile selection, structural selection, and coordination of the preparation of legal documentation. In connection with the services listed above, Ozop Capital agreed to pay $ 50,000 50,000 25,000 452,080 25,000 637,755 On April 13, 2021, the Company agreed to engage PJN Strategies, LLC (“PJN”) as a consultant. Pursuant to the agreement, the Company agreed to compensate PJN $ 20,000 84,000 252,000 On April 16, 2021, the Company signed a letter of agreement with Rubenstein Public Relations, Inc. (“RPR”). Pursuant to the letter of agreement, the Company agreed to engage RPR, effective May 1, 2021, on a month-to-month basis for $ 17,000 On March 30, 2021, OES hired 2 individuals as Co-Directors of Sales. Pursuant to their respective offers of employment, the Company agreed to an annual salary of $ 130,000 20,000 2,500,000 0.092 460,000 2,500,000 0.027 135,000 On March 15, 2021, the Company entered into a consulting agreement with Aurora Enterprises (“Aurora”). Mr. Steven Martello is a principal of Aurora. Pursuant to the agreement Mr. Martello will provide strategic analysis regarding existing markets and revenue streams as well as the development of new lines of revenue. The Company agreed to a monthly retainer fee of $ 10,000 5,000,000 30,000 On February 24, 2021, the Company entered into a consulting agreement with Christopher Ruppel. Pursuant to the agreement Mr. Ruppel was to join the Ozop Advisory Board. During the year ended December 31, 2021, the Company issued 10,000,000 2,500 0.2386 2,386,000 10,000 2,500 On February 19, 2021, the Company entered into a Joint Business Alliance agreement with Grid and Energy Master Planning, LLC (“GEMM”). GEMM will provide advisory, financing and implementation solutions for behind-the-meter customers in the areas of energy efficiency, solar, EV charging, and battery storage for OES. The GEMM services allows OES to provide one-stop-shopping in these emerging and maturing sectors. As of March 31, 2022, there has not been any transactions related to this agreement and the Company is continuing to evaluate the accounting treatment of any future transactions. On January 22, 2021, the Company issued 10,000,000 0.0056 56,000 On January 14, 2021, the Company entered into a Consulting Agreement with Mr. Allen Sosis. Pursuant to the agreement, Mr. Sosis will provide services as the Director of Business Development for the Company’s wholly owned subsidiary. Pursuant to the agreement, as amended, the Company will pay Mr. Sosis a monthly fee of $ 15,000 1,000 5,000,000 0.20 1,000,000 1,000,000 45,000 15,000 On January 6, 2021, the Company entered into a consulting agreement with Ezra Green to begin on February 8, 2021. The Company agreed to issue 10,000,000 2,500 0.0076 76,000 10,000 30,000 4,500 On March 4, 2019, the Company entered into a Separation Agreement (the “Separation Agreement”) with Salman J. Chaudhry, pursuant to which the Company agreed to pay Mr. Chaudry $ 227,200 162,085 On September 2, 2020, PCTI entered into an Agreement with a third- party. Pursuant to the terms of the agreement, in exchange for $ 750,000 PCTI agreed to pay the third-party a perpetual three percent (3%) payment of revenues, as defined in the agreement. 175,000,000 1.8 0.094 16,450,000 Legal matters We know of no material, existing or pending legal proceedings against our Company, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

STOCKHOLDERS_ EQUITY

STOCKHOLDERS’ EQUITY	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
STOCKHOLDERS’ EQUITY	NOTE 12– STOCKHOLDERS’ EQUITY Common stock During the three months ended March 31, 2022, the Company issued 5,000,000 During the three months ended March 31, 2021, holders of an aggregate of $ 760,500 116,594 428,747,654 0.002 During the three months ended March 31 2021, the Company also issued the following shares of restricted common stock: ● 100,000,000 ● 175,000000 ● 20,000,000 During the three months ended March 31, 2021, the Company also issued 330,797,987 As of March 31, 2022, the Company has 4,990,000,000 shares of $ 0.001 par value common stock authorized and there are 4,622,362,977 shares of common stock issued and outstanding. Preferred stock As of March 31, 2022, and December 31, 2021, 10,000,000 0.001 Series C Preferred Stock On July 7, 2020, the Company filed an Amended and Restated Certificate of Designation with the State of Nevada of the Company’s Series C Preferred Stock. Under the terms of the Amendment to Certificate of Designation of Series C Preferred Stock, 50,000 The holders of Series C Preferred Stock have no conversion rights and no dividend rights. For so long as any shares of the Series C Preferred Stock remain issued and outstanding, the Holder thereof, voting separately as a class, shall have the right to vote on all shareholder matters equal to sixty-seven (67%) percent of the total vote. 47,500 47,500 2,500 50,000 2,500 Series D Preferred Stock On July 7, 2020, the Company filed a Certificate of Designation with the State of Nevada of the Company’s Series D Preferred Stock. Under the terms of the Certificate of Designation of Series D Preferred Stock, 20,000 18,667 1,333 18,667 On July 27, 2021, the Company filed with the Secretary of State of the State of Nevada an Amended and Restated Certificate of Designation of Series D Preferred Stock (the “Series D Amendment”). Under the terms of the Series D Amendment, 4,570 1.5 13,200,000 3,236 1,334 3,236 The warrant has a 15 i. Up to 162 th ii. The Remainder of the Warrant representing up to 3,074 a. During every 1(one) year period, starting on the day that is the Lock Up Period Termination Date, the Holder shall have the right to exercise the Remainder of the Warrant up to a maximum number of Remaining Warrant Shares that, if converted, would be equal to no more than a maximum of 4.99% of the total number of outstanding shares of Common Stock of the Company during such given year (“Leak-Out Period”). The Leak-Out Period shall come into effect on the day that is the Lock Up Period Termination Date and remain effective on a yearly basis, for a period of 10 (ten) years thereafter, after which the Leak-Out Period will automatically terminate and become null and void. For clarity purposes the Remainder of the Warrant shall become freely exercisable at any time or times beginning on June 29, 2034 and until the Termination Date. Series E Preferred Stock On July 7, 2020, the Company filed a Certificate of Designation with the State of Nevada of the Company’s Series E Preferred Stock. Under the terms of the Certificate of Designation of Series E Preferred Stock, 3,000 1,000 500 500 1,800 200 1,000 2,000,000 3,000 0

NONCONTROLLING INTEREST

NONCONTROLLING INTEREST	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
NONCONTROLLING INTEREST	NOTE 13 – NONCONTROLLING INTEREST On August 19, 2021, the Company formed Ozop Capital. Upon formation, the Company owned 51 49 383,077 187,708 422,813

OPERATING LEASE RIGHT-OF-USE AS

OPERATING LEASE RIGHT-OF-USE ASSETS AND OPERATING LEASE LIABILITIES	3 Months Ended
	Mar. 31, 2022
Operating Lease Right-of-use Assets And Operating Lease Liabilities
OPERATING LEASE RIGHT-OF-USE ASSETS AND OPERATING LEASE LIABILITIES	NOTE 14 - OPERATING LEASE RIGHT-OF-USE ASSETS AND OPERATING LEASE LIABILITIES On October 25, 2019, PCTI executed a non-cancellable lease for office and industrial space which began December 1, 2019 and expires on November 30, 2022 7.5 84,278 185,139 On April 14, 2021, the Company entered into a five 8,100 May 31, 2026 13,148 2.4 7.5 702,888 In adopting Topic 842, the Company has elected the ‘package of practical expedients’, which permit it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter is not applicable to the Company. In addition, the Company elected not to apply ASC Topic 842 to arrangements with lease terms of 12 months or less. Right-of- use assets are summarized below: SCHEDULE OF RIGHT-OF-USE ASSETS March 31, 2022 Office and warehouse lease $ 888,026 Less: Accumulated Amortization (230,687 ) Right-of-use asset, net $ 657,339 SCHEDULE OF OPERATING LEASE LIABILITIES March 31, 2022 Lease liability $ 663,866 Less current portion (177,858 ) Long term portion $ 486,008 Maturity of lease liabilities are as follows: SCHEDULE OF MATURITY OF LEASE LIABILITIES Amount For the year ended December 31, 2022 $ 179,548 For the year ended December 31, 2023 167,858 For the year ended December 31, 2024 171,840 For the year ended December 31, 2025 175,942 For the year ended December 31, 2026 74,030 Total $ 769,218 Less present value discount (105,352 ) Lease liability $ 663,866

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 15 – SUBSEQUENT EVENTS On April 4th, 2022, the Company and GHS Investments LLC (“GHS”). signed a Securities Purchase Agreement (the “GHS Purchase Agreement”) for the sale of up to Two Hundred Million ( 200,000,000 October 4, 2022 The Company has evaluated subsequent events through the date the financial statements were issued. The Company has determined that there are no other such events that warrant disclosure or recognition in the financial statements, except as stated herein.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING PRONOUNCEMENTS (Policies)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of March 31, 2022, and the results of operations and cash flows for the periods presented. The results of operations for the three months ended March 31, 2022, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in the Company’s Current Report on Form 10-K/A filed on April 26, 2022. The unaudited condensed consolidated financial statements include the accounts of the Company and Ozop Energy Systems, Inc. and the Company’s other wholly owned subsidiaries PCTI, Ozop LLC, Ozop HK and Spinus, LLC (“Spinus”) and the Company’s majority owned subsidiary Ozop Capital Partners, Inc. All intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value. Cash and cash equivalent balances may, at certain times, exceed federally insured limits. The Company has no cash equivalents at March 31, 2022, and December 31, 2021.
Sales Concentration and credit risk	Sales Concentration and credit risk Following is a summary of customers who accounted for more than ten percent (10%) of the Company’s revenues for the three months ended March 31, 2022, and 2021, and their accounts receivable balance as of March 31, 2022: SCHEDULES OF CONCENTRATION OF RISK, BY RISK FACTOR Sales % Sales % Accounts Customer A 18.5 % N/A $ 420,390 Customer B 14.7 % N/A 308,345 Customer C 14.5 % N/A - Customer D 13.5 % N/A 3,835 Customer E N/A 95 % -
Accounts Receivable	Accounts Receivable The Company records accounts receivable at the time products and services are delivered. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience.
Inventory	Inventory Inventories are valued at the lower of cost or net realizable value, with cost determined on the first-in, first-out basis. Inventory costs include finished goods, material, labor and manufacturing overhead. In evaluating the net realizable value of inventory, management also considers, if applicable, other factors, including known trends, market conditions, currency exchange rates and other such issues. The components of inventories at March 31, 2022, and December 31, 2021, are as follows: SCHEDULE OF INVENTORY March 31, December 31, Raw materials $ 236,959 $ 234,168 Work in process 58,202 43,704 Finished goods 2,041,444 788,110 Inventory net $ 2,336,605 $ 1,065,982
Purchase concentration	Purchase concentration OES purchases finished renewable energy products from its’ suppliers. For the three months ended March 31, 2022, there were four suppliers that accounted for 35.7% 24.1% 12.6% 10.1% 20% The principal purchases by PCTI are comprised of parts and raw materials that PCTI assembles and manufactures and sells to its customers. There were no suppliers who accounted for more than ten percent (10%) of the Company’s purchases for the three months ended March 31, 2021.
Property, plant and equipment	Property, plant and equipment Property and equipment are stated at cost, and depreciation is provided by use of a straight-line method over the estimated useful lives of the assets. The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable. The estimated useful lives of property and equipment is as follows: SCHEDULE OF USEFUL LIFE OF PROPERTY AND EQUIPMENT ASSETS Office furniture and equipment 3 5 Warehouse equipment 7
Revenue Recognition	Revenue Recognition The Company recognizes revenue in accordance with ASC 606, from the commercial sales of products by: (1) identify the contract (if any) with a customer; (2) identify the performance obligations in the contract (if any); (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract (if any); and (5) recognize revenue when each performance obligation is satisfied. Under ASC 606, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. Other than The Company has no outstanding contracts with any of its’ customers. The Company recognizes revenue when title, ownership, and risk of loss pass to the customer, all of which occurs upon shipment or delivery of the product and is based on the applicable shipping terms. For contracts with customers, ownership of the goods and associated revenue are transferred to customers at a point in time, generally upon shipment of a product to the customer or receipt of the product by the customer and without significant judgments. Advance payments are typically required for commercial customers and are recorded as current liability until revenue is recognized. Advance payments are not required for government customers. The majority of contracts typically require payment within 30 to 60 days after transfer of ownership to the customer. For the periods covered herein, we did not have post shipment obligations such as training or installation, customer acceptance provisions, credits and discounts, rebates and price protection, or other similar privileges. The following table disaggregates our revenue by major source for the three months ended March 31, 2022 and 2021: DISAGGREGATION OF REVENUE Three months ended Three months ended Sourced and distributed products $ 2,919,322 $ - Manufactured products 162,916 795,554 Total $ 3,082,238 $ 795,554 Revenues from sourced and distributed products are purchased from suppliers as finished goods and the Company brings the finished goods into our California warehouse to fill orders as well as to build inventory for future sales orders. From time to time for some of our larger orders we may have our suppliers ship directly to our customers to avoid extra shipping charges. For manufactured products, there is usually a bidding process by branches of the military or other large firms that need mostly battery charging and storage systems for large industrial projects. We would then purchase the raw materials and parts needed to build out the project in our Pennsylvania warehouse.
Advertising and Marketing Expenses	Advertising and Marketing Expenses The Company expenses advertising and marketing costs as incurred. For the three months ended March 31, 2022, and 2021, the Company recorded advertising and marketing expenses of $ 3,263 22,590
Research and Development	Research and Development Costs and expenses that can be clearly identified as research and development are charged to expense as incurred. For the three months ended March 31, 2022, and 2021, the Company did not record any research and development expenses.
Convertible Instruments	Convertible Instruments The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities. Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of this note transaction and the effective conversion price embedded in this note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption. The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt and equity linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level. The following are the hierarchical levels of inputs to measure fair value: ● Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities. ● Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means. ● Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available. From time to time, certain of the Company’s embedded conversion features on debt and outstanding warrants have been treated as derivative liabilities for accounting purposes under ASC 815 due to insufficient authorized shares to fully settle conversion features of the instruments if exercised. In this case, the Company utilized the latest inception date sequencing method to reclassify outstanding instruments as derivative instruments. These contracts were recognized at fair value with changes in fair value recognized in earnings until such time as the conditions giving rise to such derivative liability classification were settled. The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable and accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments. The following table represents the Company’s derivative instruments that are measured at fair value on a recurring basis as of March 31, 2022, and December 31, 2021, for each fair value hierarchy level: SCHEDULE OF DERIVATIVE INSTRUMENTS March 31, 2022 Derivative Total Level I $ - $ - Level II $ - $ - Level III $ 16,601,498 $ 16,601,498 December 31, 2021 Derivative Total Level I $ - $ - Level II $ - $ - Level III $ 20,966,701 $ 20,966,701
Leases	Leases The Company accounts for leases under ASU 2016-02 (see Note 14), applying the package of practical expedients to leases that commenced before the effective date whereby the Company elected to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. For contracts entered into on or after the effective date, at the inception of a contract the Company assess whether the contract is, or contains, a lease. Our assessment is based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use of the asset throughout the period, and (3) whether we have the right to direct the use of the asset. We allocate the consideration in the contract to each lease component based on its relative stand-alone price to determine the lease payments. Operating lease ROU assets represent the right to use the leased asset for the lease term and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit rate, the Company used an incremental borrowing rate of 7.5%, for the existing lease, based on the information available at the adoption date in determining the present value of future payments. Operating lease expense is recognized pursuant to on a straight-line basis over the lease term and is included in rent in the condensed consolidated statements of operations.
Income Taxes	Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance on deferred tax assets is established when management considers it is more likely than not that some portion or all of the deferred tax assets will not be realized. Tax benefits from an uncertain tax position are only recognized if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting periods presented
Segment Policy	Segment Policy The Company has no reportable segments as it operates in one segment; renewable energy.
Earnings (Loss) Per Share	Earnings (Loss) Per Share The Company reports earnings (loss) per share in accordance with ASC 260, “Earnings per Share.” Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during each period. Diluted earnings per share is computed by dividing net loss by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. As of March 31, 2022, and 2021, the Company’s dilutive securities are convertible into approximately 7,689,322,026 14,215,032,540 SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE March 31, 2022 March 31, 2021 Convertible preferred stock (1) 6,933,544,491 13,357,511,800 Unexercised common stock purchase warrants (1) 672,024,518 707,950,819 Convertible notes payable 2,461,916 144,569,921 Promissory note payable (1) 81,291,096 Common stock to be issued - 5,000,000 7,689,322,026 14,215,032,540 (1) The potentially dilutive shares included in the above table are limited whereby the conversion or exercise cannot result in the beneficial owner holding more than 4.99
Recent Accounting Pronouncements	Recent Accounting Pronouncements In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging —Contracts in Entity’ Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’ Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company does not believe the adoption of the ASU will have a material impact on the Company’s financial position, results of operations or cash flows. Other than the above, there have no recent accounting pronouncements or changes in accounting pronouncements during the period ended March 31, 2022, that are of significance or potential significance to the Company.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING PRONOUNCEMENTS (Tables)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
SCHEDULES OF CONCENTRATION OF RISK, BY RISK FACTOR	Following is a summary of customers who accounted for more than ten percent (10%) of the Company’s revenues for the three months ended March 31, 2022, and 2021, and their accounts receivable balance as of March 31, 2022: SCHEDULES OF CONCENTRATION OF RISK, BY RISK FACTOR Sales % Sales % Accounts Customer A 18.5 % N/A $ 420,390 Customer B 14.7 % N/A 308,345 Customer C 14.5 % N/A - Customer D 13.5 % N/A 3,835 Customer E N/A 95 % -
SCHEDULE OF INVENTORY	The components of inventories at March 31, 2022, and December 31, 2021, are as follows: SCHEDULE OF INVENTORY March 31, December 31, Raw materials $ 236,959 $ 234,168 Work in process 58,202 43,704 Finished goods 2,041,444 788,110 Inventory net $ 2,336,605 $ 1,065,982
SCHEDULE OF USEFUL LIFE OF PROPERTY AND EQUIPMENT ASSETS	SCHEDULE OF USEFUL LIFE OF PROPERTY AND EQUIPMENT ASSETS Office furniture and equipment 3 5 Warehouse equipment 7
DISAGGREGATION OF REVENUE	The following table disaggregates our revenue by major source for the three months ended March 31, 2022 and 2021: DISAGGREGATION OF REVENUE Three months ended Three months ended Sourced and distributed products $ 2,919,322 $ - Manufactured products 162,916 795,554 Total $ 3,082,238 $ 795,554
SCHEDULE OF DERIVATIVE INSTRUMENTS	The following table represents the Company’s derivative instruments that are measured at fair value on a recurring basis as of March 31, 2022, and December 31, 2021, for each fair value hierarchy level: SCHEDULE OF DERIVATIVE INSTRUMENTS March 31, 2022 Derivative Total Level I $ - $ - Level II $ - $ - Level III $ 16,601,498 $ 16,601,498 December 31, 2021 Derivative Total Level I $ - $ - Level II $ - $ - Level III $ 20,966,701 $ 20,966,701
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE	SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE March 31, 2022 March 31, 2021 Convertible preferred stock (1) 6,933,544,491 13,357,511,800 Unexercised common stock purchase warrants (1) 672,024,518 707,950,819 Convertible notes payable 2,461,916 144,569,921 Promissory note payable (1) 81,291,096 Common stock to be issued - 5,000,000 7,689,322,026 14,215,032,540 (1) The potentially dilutive shares included in the above table are limited whereby the conversion or exercise cannot result in the beneficial owner holding more than 4.99

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	3 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT	The following table summarizes the Company’s property and equipment: PROPERTY AND EQUIPMENT March 31, 2022 December 31, 2021 Office equipment $ 300,083 $ 260,083 Less: Accumulated Depreciation (139,378 ) (127,194 ) Property and Equipment, Net $ 160,705 $ 132,889

DERIVATIVE LIABILITIES (Tables)

DERIVATIVE LIABILITIES (Tables)	3 Months Ended
	Mar. 31, 2022
Derivative Liabilities
SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE	A summary of the activity related to derivative liabilities for the three months ended March 31, 2022, is as follows: SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE Derivative liabilities associated with warrants Derivative liabilities associated with convertible notes Total derivative liabilities Balance December 31, 2021 $ 20,938,755 $ 27,946 $ 20,966,701 Change in fair value (4,365,194 ) (9 ) (4,365,203 ) Balance March 31, 2022 $ 16,573,561 $ 27,937 $ 16,601,498

NOTES PAYABLE (Tables)

NOTES PAYABLE (Tables)	3 Months Ended
	Mar. 31, 2022
Notes Payable
SCHEDULE OF NOTES PAYABLE	The Company has the following note payables outstanding: SCHEDULE OF NOTES PAYABLE March 31, 2022 December 31, 2021 $ 134,681 $ 134,681 Note payable bank, interest at 7.75 December 5, 2021 $ 134,681 $ 134,681 Note payable bank, interest at 6.5 December 26, 2021 344,166 344,166 Economic Injury Disaster Loan 10,000 10,000 Paycheck Protection Program loan 100,400 100,400 Notes payable, interest at 8 January 5, 2020 45,000 45,000 Other, due on demand, interest at 6 50,000 50,000 Note payable $ 750,000 12 August 24, 2021 375,000 375,000 Note payable $ 389,423 18 November 6, 2023 389,423 389,423 Note payable $ 1,000,000 12 November 13, 2021 1,000,000 1,000,000 Note payable $ 2,200,000 12 February 9, 2022 243,833 2,200,000 1,956,167 Note payable $ 11,110,000 12 March 17, 2022 2,314,583 11,110,000 8,795,417 Note payable $ 3,300,000 12 December 7, 2022 2,278,820 3,099,524 1,021,180 200,476 Sub- total notes payable 16,779,851 13,400,730 Less long-term portion 389,423 389,423 Current portion of notes payable, net of discount $ 16,390,428 $ 13,011,307

RELATED PARTY TRANSACTIONS (Tab

RELATED PARTY TRANSACTIONS (Tables)	3 Months Ended
	Mar. 31, 2022
Related Party Transactions [Abstract]
SCHEDULE OF EXPENSES TO OFFICERS	For the three months ended March 31, 2022, and 2021, the Company recorded expenses to its officers in the following amounts: SCHEDULE OF EXPENSES TO OFFICERS 2021 2020 Three months ended 2022 2021 CEO, parent $ 390,000 $ 279,999 CEO, parent- Series E Preferred Stock - 1,800,000 President, subsidiary (resigned July 2021) - 35,009 Total $ 125,583 $ 2,115,008

OPERATING LEASE RIGHT-OF-USE _2

OPERATING LEASE RIGHT-OF-USE ASSETS AND OPERATING LEASE LIABILITIES (Tables)	3 Months Ended
	Mar. 31, 2022
Operating Lease Right-of-use Assets And Operating Lease Liabilities
SCHEDULE OF RIGHT-OF-USE ASSETS	Right-of- use assets are summarized below: SCHEDULE OF RIGHT-OF-USE ASSETS March 31, 2022 Office and warehouse lease $ 888,026 Less: Accumulated Amortization (230,687 ) Right-of-use asset, net $ 657,339
SCHEDULE OF OPERATING LEASE LIABILITIES	SCHEDULE OF OPERATING LEASE LIABILITIES March 31, 2022 Lease liability $ 663,866 Less current portion (177,858 ) Long term portion $ 486,008
SCHEDULE OF MATURITY OF LEASE LIABILITIES	Maturity of lease liabilities are as follows: SCHEDULE OF MATURITY OF LEASE LIABILITIES Amount For the year ended December 31, 2022 $ 179,548 For the year ended December 31, 2023 167,858 For the year ended December 31, 2024 171,840 For the year ended December 31, 2025 175,942 For the year ended December 31, 2026 74,030 Total $ 769,218 Less present value discount (105,352 ) Lease liability $ 663,866

GOING CONCERN AND MANAGEMENT__2

GOING CONCERN AND MANAGEMENT’S PLANS (Details Narrative) - USD ($)	Apr. 04, 2022	Mar. 15, 2021	Mar. 31, 2022	Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Retained Earnings (Accumulated Deficit)			$ 218,520,372	$ 217,326,611
Working capital deficit			29,485,841
Derivative Liability, Current			16,601,498	$ 20,966,701
Debt instrument default amount			$ 15,369,247
Common stock maturity period		Dec. 26, 2021
Registration Statement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during the period			30,000,000
Securities Purchase Agreement [Member] | GHS Investments LLC [Member] | Subsequent Event [Member] | Common Stock [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during the period	200,000,000
Common stock maturity period	Oct. 4, 2022
Agreement description	The purchase price shall be 85% of lowest VWAP for the ten (10) days preceding the Company’s notice to GHS for the sale of the Company’s common stock. On April 8, 2022, the Company filed a Prospectus Supplement to the Registration Statement dated October 14, 2021, regarding the GHS Purchase Agreement

SCHEDULES OF CONCENTRATION OF R

SCHEDULES OF CONCENTRATION OF RISK, BY RISK FACTOR (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Customer A [Member]
Product Information [Line Items]
Accounts Receivable, after Allowance for Credit Loss	$ 420,390
Customer A [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]
Product Information [Line Items]
Concentration Risk, Percentage	18.50%
Customer B [Member]
Product Information [Line Items]
Accounts Receivable, after Allowance for Credit Loss	$ 308,345
Customer B [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]
Product Information [Line Items]
Concentration Risk, Percentage	14.70%
Customer C [Member]
Product Information [Line Items]
Accounts Receivable, after Allowance for Credit Loss
Customer C [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]
Product Information [Line Items]
Concentration Risk, Percentage	14.50%
Customer D [Member]
Product Information [Line Items]
Accounts Receivable, after Allowance for Credit Loss	$ 3,835
Customer D [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]
Product Information [Line Items]
Concentration Risk, Percentage	13.50%
Customer E [Member]
Product Information [Line Items]
Accounts Receivable, after Allowance for Credit Loss
Customer E [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]
Product Information [Line Items]
Concentration Risk, Percentage		95.00%

SCHEDULE OF INVENTORY (Details)

SCHEDULE OF INVENTORY (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Raw materials	$ 236,959	$ 234,168
Work in process	58,202	43,704
Finished goods	2,041,444	788,110
Inventory net	$ 2,336,605	$ 1,065,982

SCHEDULE OF USEFUL LIFE OF PROP

SCHEDULE OF USEFUL LIFE OF PROPERTY AND EQUIPMENT ASSETS (Details)	3 Months Ended
	Mar. 31, 2022
Warehouse Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	7 years
Minimum [Member] | Office Furniture And Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Maximum [Member] | Office Furniture And Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	5 years

DISAGGREGATION OF REVENUE (Deta

DISAGGREGATION OF REVENUE (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Product Information [Line Items]
Total	$ 3,082,238	$ 795,554
Sourced and Distributed Products [Member]
Product Information [Line Items]
Total	2,919,322
Manufactured Products [Member]
Product Information [Line Items]
Total	$ 162,916	$ 795,554

SCHEDULE OF DERIVATIVE INSTRUME

SCHEDULE OF DERIVATIVE INSTRUMENTS (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative Liabilities
Fair Value, Net Asset (Liability)
Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative Liabilities
Fair Value, Net Asset (Liability)
Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative Liabilities	16,601,498	20,966,701
Fair Value, Net Asset (Liability)	$ 16,601,498	$ 20,966,701

SCHEDULE OF ANTIDILUTIVE SECURI

SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) - shares		3 Months Ended
		Mar. 31, 2022	Mar. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive shares of common stock		7,689,322,026	14,215,032,540
Convertible Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive shares of common stock	[1]	6,933,544,491	13,357,511,800
Unexercised Common Stock Purchase Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive shares of common stock	[1]	672,024,518	707,950,819
Convertible Notes Payable [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive shares of common stock		2,461,916	144,569,921
Promissory Note Payable [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive shares of common stock	[1]	81,291,096
Common Stock To Be Issued [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive shares of common stock			5,000,000
[1]	The potentially dilutive shares included in the above table are limited whereby the conversion or exercise cannot result in the beneficial owner holding more than 4.99

SCHEDULE OF ANTIDILUTIVE SECU_2

SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) (Parenthetical)	Mar. 31, 2022
Accounting Policies [Abstract]
Beneficial ownership	4.99%

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING PRONOUNCEMENTS (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Product Information [Line Items]
Marketing and Advertising Expense	$ 3,263	$ 22,590
Income Tax Examination, Likelihood of Unfavorable Settlement	greater than fifty percent likelihood of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting periods presented
Dilutive securities common stock, shares	7,689,322,026	14,215,032,540
Suppliers One [Member] | Accounts Payable [Member] | Supplier Concentration Risk [Member]
Product Information [Line Items]
Concentration of credit risk	35.70%
Suppliers Two [Member] | Accounts Payable [Member] | Supplier Concentration Risk [Member]
Product Information [Line Items]
Concentration of credit risk	24.10%
Suppliers Three [Member] | Accounts Payable [Member] | Supplier Concentration Risk [Member]
Product Information [Line Items]
Concentration of credit risk	12.60%
Suppliers Four [Member] | Accounts Payable [Member] | Supplier Concentration Risk [Member]
Product Information [Line Items]
Concentration of credit risk	10.10%
Two Vendor [Member] | Accounts Payable [Member] | Supplier Concentration Risk [Member]
Product Information [Line Items]
Concentration of credit risk	20.00%

PROPERTY AND EQUIPMENT (Details

PROPERTY AND EQUIPMENT (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Less: Accumulated Depreciation	$ (139,378)	$ (127,194)
Property and Equipment, Net	160,705	132,889
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Office equipment	$ 300,083	$ 260,083

PROPERTY AND EQUIPMENT (Detai_2

PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Property, Plant and Equipment [Abstract]
Depreciation	$ 12,184	$ 8,328

CONVERTIBLE NOTES PAYABLE (Deta

CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
15% Promissory Note [Member]
Short-Term Debt [Line Items]
Long term debt, gross	$ 25,000	$ 25,000

SCHEDULE OF DERIVATIVE LIABILIT

SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Derivative liability	$ 20,966,701
Change in fair value	(4,365,203)	$ 52,197,902
Derivative liability	16,601,498
Derivative Liabilities Associated With Warrants [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Derivative liability	20,938,755
Change in fair value	(4,365,194)
Derivative liability	16,573,561
Derivative Liabilities Associated With Convertible Notes [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Derivative liability	27,946
Change in fair value	(9)
Derivative liability	$ 27,937

DERIVATIVE LIABILITIES (Details

DERIVATIVE LIABILITIES (Details Narrative)	Mar. 31, 2022USD ($)$ / shares	Dec. 31, 2021USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liabilities | $	$ 16,601,498	$ 20,966,701
Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk free interest rates	1.06	0.19
Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk free interest rates	2.08	48
Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk free interest rates	2.39	0.99
Measurement Input, Option Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk free interest rates	83	92
Measurement Input, Option Volatility [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk free interest rates	226	344
Measurement Input, Option Volatility [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk free interest rates	331	366
Measurement Input, Exercise Price [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk free interest rates	0.006
Measurement Input, Exercise Price [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk free interest rates	0.15

SCHEDULE OF NOTES PAYABLE (Deta

SCHEDULE OF NOTES PAYABLE (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Short-Term Debt [Line Items]
Sub- total notes payable	$ 16,779,851	$ 13,400,730
Less long-term portion	389,423	389,423
Current portion of notes payable, net of discount	16,390,428	13,011,307
Note Payable [Member]
Short-Term Debt [Line Items]
Sub- total notes payable	134,681	134,681
Note Payable One [Member]
Short-Term Debt [Line Items]
Sub- total notes payable	344,166	344,166
Economic Injury Disaster Loan [Member]
Short-Term Debt [Line Items]
Sub- total notes payable	10,000	10,000
Paycheck Protection Programloan [Member]
Short-Term Debt [Line Items]
Sub- total notes payable	100,400	100,400
Note Payable Two [Member]
Short-Term Debt [Line Items]
Sub- total notes payable	45,000	45,000
Other [Member]
Short-Term Debt [Line Items]
Sub- total notes payable	50,000	50,000
Note Payable Three [Member]
Short-Term Debt [Line Items]
Sub- total notes payable	375,000	375,000
Note Payable Four [Member]
Short-Term Debt [Line Items]
Sub- total notes payable	389,423	389,423
Note Payable Five [Member]
Short-Term Debt [Line Items]
Sub- total notes payable	1,000,000	1,000,000
Note Payable Six [Member]
Short-Term Debt [Line Items]
Sub- total notes payable	2,200,000	1,956,167
Note Payable Seven [Member]
Short-Term Debt [Line Items]
Sub- total notes payable	11,110,000	8,795,417
Note Payable Eight [Member]
Short-Term Debt [Line Items]
Sub- total notes payable	$ 1,021,180	$ 200,476

SCHEDULE OF NOTES PAYABLE (De_2

SCHEDULE OF NOTES PAYABLE (Details) (Parenthetical) - USD ($)	Mar. 15, 2021	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021	Oct. 26, 2016
Short-Term Debt [Line Items]
Debt Instrument, interest rate, stated percentage					7.75%
Debt Instrument, maturity date	Dec. 26, 2021
Debt Instrument, face amount				$ 760,500
Note Payable [Member]
Short-Term Debt [Line Items]
Debt Instrument, interest rate, stated percentage		7.75%	7.75%
Debt Instrument, maturity date		Dec. 5, 2021	Dec. 5, 2021
Note Payable One [Member]
Short-Term Debt [Line Items]
Debt Instrument, interest rate, stated percentage		6.50%	6.50%
Debt Instrument, maturity date		Dec. 26, 2021	Dec. 26, 2021
Note Payable Two [Member]
Short-Term Debt [Line Items]
Debt Instrument, interest rate, stated percentage		8.00%	8.00%
Debt Instrument, maturity date		Jan. 5, 2020	Jan. 5, 2020
Other [Member]
Short-Term Debt [Line Items]
Debt Instrument, interest rate, stated percentage		6.00%	6.00%
Note Payable Three [Member]
Short-Term Debt [Line Items]
Debt Instrument, interest rate, stated percentage		12.00%	12.00%
Debt Instrument, maturity date		Aug. 24, 2021	Aug. 24, 2021
Debt Instrument, face amount		$ 750,000	$ 750,000
Note Payable Four [Member]
Short-Term Debt [Line Items]
Debt Instrument, interest rate, stated percentage		18.00%	18.00%
Debt Instrument, maturity date		Nov. 6, 2023	Nov. 6, 2023
Debt Instrument, face amount		$ 389,423	$ 389,423
Note Payable Five [Member]
Short-Term Debt [Line Items]
Debt Instrument, interest rate, stated percentage		12.00%	12.00%
Debt Instrument, maturity date		Nov. 13, 2021	Nov. 13, 2021
Debt Instrument, face amount		$ 1,000,000	$ 1,000,000
Note Payable Six [Member]
Short-Term Debt [Line Items]
Debt Instrument, interest rate, stated percentage		12.00%	12.00%
Debt Instrument, maturity date		Feb. 9, 2022	Feb. 9, 2022
Debt Instrument, face amount		$ 2,200,000	$ 2,200,000
Debt Instrument, unamortized discount			$ 243,833
Note Payable Seven [Member]
Short-Term Debt [Line Items]
Debt Instrument, interest rate, stated percentage		12.00%	12.00%
Debt Instrument, maturity date		Mar. 17, 2022	Mar. 17, 2022
Debt Instrument, face amount		$ 11,110,000	$ 11,110,000
Debt Instrument, unamortized discount			$ 2,314,583
Note Payable Eight [Member]
Short-Term Debt [Line Items]
Debt Instrument, interest rate, stated percentage		12.00%	12.00%
Debt Instrument, maturity date		Dec. 7, 2022	Dec. 7, 2022
Debt Instrument, face amount		$ 3,300,000	$ 3,300,000
Debt Instrument, unamortized discount		$ 2,278,820	$ 3,099,524

NOTES PAYABLE (Details Narrativ

NOTES PAYABLE (Details Narrative) - USD ($)	Dec. 13, 2021	Dec. 07, 2021	Mar. 23, 2021	Mar. 17, 2021	Mar. 15, 2021	Feb. 16, 2021	Feb. 09, 2021	Nov. 20, 2020	Nov. 13, 2020	Nov. 06, 2020	Aug. 25, 2020	Aug. 24, 2020	Jul. 23, 2020	Jul. 14, 2020	Apr. 20, 2020	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	May 03, 2021	Dec. 31, 2020	Oct. 26, 2016
Debt Instrument, Interest Rate, Stated Percentage																					7.75%
Debt Instrument, Face Amount																	$ 760,500
Debt Instrument, Maturity Date					Dec. 26, 2021
Proceeds from Notes Payable																	$ 12,000,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights																	330,797,987
Amortization of Debt Discount (Premium)																3,379,121	$ 40,414,627
Derivative Liability																16,601,498		$ 20,966,701
Notes Payable																$ 16,779,851		$ 13,400,730
Debt Instrument, Increase, Accrued Interest																	$ 116,594
Notes Payable to Bank					$ 350,000																$ 210,000
Short-Term Bank Loans and Notes Payable					$ 350,000
Common Stock, Shares, Issued																4,622,362,977		4,617,362,977
Paycheck Protection Program [Member]
Debt Instrument, Maturity Date															Apr. 20, 2022
Loans Payable to Bank															$ 100,400	$ 100,400		$ 100,400
Accounts Payable, Interest-Bearing, Interest Rate															1.00%
PCTI [Member]
Notes Payable																		134,681		$ 151,469
PCTI [Member] | Personal Guarantee Of Chis [Member]
Notes Payable																		344,166		$ 345,211
Economic Injury Disaster Loan [Member]
Proceeds from Notes Payable														$ 10,000
Debt Instrument, Description														The first payment due is deferred one year. The loan balance of March 31, 2022, and December 31, 2021 was $10,000 and has been classified in notes payable
Debt Instrument, Decrease, Forgiveness														$ 10,000
Holder [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights																125,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights																$ 0.008
Warrants and Rights Outstanding, Term																5 years
Promissory Note [Member]
Debt Instrument, Face Amount																		375,000
Debt Instrument, Unamortized Discount																$ 375,000		375,000
Interest Payable																112,747		90,247
Common Stock, Shares, Issued																			75,000,000
Promissory Note [Member] | Maximum [Member]
Debt Instrument, Interest Rate, Stated Percentage					6.50%
Promissory Note [Member] | Prime Rate [Member]
Debt Instrument, Interest Rate, Stated Percentage					325.00%
Promissory Note [Member] | Lender [Member]
Debt Instrument, Interest Rate, Stated Percentage				12.00%
Debt Instrument, Face Amount				$ 11,110,000												11,110,000		11,110,000
Debt Instrument, Maturity Date				Mar. 17, 2022
Debt Instrument, Unamortized Discount				$ 1,000,000														2,314,583
Proceeds from Notes Payable			$ 10,000,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				250,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 0.13
Amortization of Debt Discount (Premium)																231,250
Amortization of Warrant Discount																2,083,333
Carrying amount																11,100,000		8,795,417
[custom:LenderCosts]				$ 110,000
Interest Payable																1,362,421		1,033,687
Promissory Note [Member] | Lender [Member] | Valuation Technique, Option Pricing Model [Member]
Debt Instrument, Unamortized Discount																10,000,000
Interest Expense																23,248,433
Derivative Liability																		32,248,433
Fair value of adjustment of warrants																33,248,433
Promissory Note [Member] | Lender [Member] | December Seven Two Thousand Twenty Two [Member]
Debt Instrument, Interest Rate, Stated Percentage		12.00%
Debt Instrument, Face Amount		$ 3,300,000														3,300,000		3,300,000
Debt Instrument, Maturity Date		Dec. 7, 2022
Debt Instrument, Unamortized Discount		$ 300,000														2,278,820		3,099,524
Proceeds from Notes Payable	$ 3,000,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		75,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.039
Amortization of Debt Discount (Premium)																75,000
Interest Expense																2,982,815
Derivative Liability																2,982,815
Amortization of Warrant Discount																745,704
Carrying amount																1,021,180		200,476
Promissory Note [Member] | Holder [Member]
Debt Instrument, Interest Rate, Stated Percentage									12.00%	12.00%		12.00%
Debt Instrument, Face Amount									$ 1,000,000	$ 389,423		$ 750,000	$ 210,000			1,000,000		1,000,000
Debt Instrument, Maturity Date									Nov. 13, 2021	Nov. 6, 2023
Proceeds from Notes Payable								$ 890,000			$ 663,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights										60,000,000		122,950,819
Class of Warrant or Right, Exercise Price of Warrants or Rights										$ 0.0075		$ 0.0061
Interest Payable																194,630		135,452
Debt Instrument, Description									Principal payments shall be made in six instalments of $166,667 commencing 180 days from the issue date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the maturity date			Principal payments shall be made in six instalments of $125,000 commencing 180 days from the Issue Date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the Maturity Date. The Holder shall have the right from time to time, and at any time following an event of default, as defined on the agreement, to convert all or any part of the outstanding and unpaid principal, interest and any other amounts due into fully paid and non-assessable shares of common stock of the Company, at the lower of i) the Trading Price (as defined in the agreement) during the previous five trading days prior to the Issuance Date or ii) the volume weighted average price during the five trading days ending on the day preceding the conversion date
Legal Fees								$ 110,000			$ 87,000
Warrants and Rights Outstanding, Term										5 years
Notes Payable										$ 120,000
Debt Instrument, Increase, Accrued Interest										$ 8,716			$ 15,707
Promissory Note [Member] | Holder [Member] | Nine Instalments [Member]
Interest Expense																		56,188
Adjustments to Additional Paid in Capital, Warrant Issued												$ 750,000
Promissory Note One [Member] | Lender [Member]
Debt Instrument, Interest Rate, Stated Percentage							12.00%
Debt Instrument, Face Amount							$ 2,200,000									2,200,000		2,200,000
Debt Instrument, Maturity Date							Feb. 9, 2022
Debt Instrument, Unamortized Discount							$ 200,000											243,833
Proceeds from Notes Payable						$ 2,000,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights							50,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 0.15
Amortization of Debt Discount (Premium)																22,167
Carrying amount																		1,956,167
Interest Payable																295,825		$ 230,729
Promissory Note One [Member] | Lender [Member] | Valuation Technique, Option Pricing Model [Member]
Debt Instrument, Unamortized Discount																2,000,000
Interest Expense																15,659,506
Derivative Liability																17,659,506
Fair value of adjustment of warrants																17,659,506
Promissory Note One [Member] | Lenders [Member]
Amortization of Warrant Discount																$ 221,667

DEFERRED LIABILITY (Details Nar

DEFERRED LIABILITY (Details Narrative) - USD ($)	Feb. 26, 2021	Sep. 02, 2020	Mar. 31, 2021	Mar. 31, 2022	Dec. 31, 2021
Deferred liability, current				$ 750,000	$ 750,000
PCTI [Member] | Exchange Agreement [Member]
Deferred liability, current		$ 750,000
Product liability contingency, third party recovery, percentage		3.00%
Deferred compensation exchanged for common stock	175,000,000
Royalty percentage	1.80%
Shares issued, price per share			$ 0.094	$ 0.094
Payments of debt restructuring costs			$ 16,450,000

DEFERRED REVENUE (Details Narra

DEFERRED REVENUE (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2020	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Increase (Decrease) in Due to Related Parties		$ 64,353
Extended Product Warranty Description		payment of a three- year extended warranty
Revenue recognized	$ 5,363
Deferred revenue	41,115
Deferred revenue, current	21,451		$ 21,451
Deferred revenue, non-current	$ 19,664		$ 25,026

SCHEDULE OF EXPENSES TO OFFICER

SCHEDULE OF EXPENSES TO OFFICERS (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Related Party Transaction [Line Items]
Total	$ 125,583	$ 2,115,008
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Total	390,000	279,999
Chief Executive Officer Series E Preferred Stock [Member]
Related Party Transaction [Line Items]
Total		1,800,000
President Subsidiary [Member]
Related Party Transaction [Line Items]
Total		$ 35,009

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	Jan. 02, 2022	Jul. 13, 2021	Apr. 16, 2021	Mar. 21, 2021	Aug. 28, 2020	Jul. 10, 2020	Mar. 31, 2022	Jan. 31, 2022	Mar. 31, 2022	Dec. 31, 2021
Related Party Transaction [Line Items]
Stock based compensation									$ 135,000
Number of preferred stock shares authorized							10,000,000		10,000,000	10,000,000
Series E Preferred Stock [Member]
Related Party Transaction [Line Items]
Number of shares issued, shares				2,000
Number of preferred stock shares authorized			2,000				3,000		3,000	3,000
Series C Preferred Stock [Member]
Related Party Transaction [Line Items]
Number of preferred stock shares authorized							50,000		50,000	50,000
Series D Preferred Stock [Member]
Related Party Transaction [Line Items]
Number of preferred stock shares authorized							4,570		4,570	4,570
Employment Agreement [Member]
Related Party Transaction [Line Items]
Amount of initial annual compensation	$ 240,000
Definitive Agreement [Member] | Series C Preferred Stock [Member]
Related Party Transaction [Line Items]
Number of shares purchased		47,500
[custom:StockIssuedDuringPeriodValuePurchased]		$ 11,250,000
Definitive Agreement [Member] | Series D Preferred Stock [Member]
Related Party Transaction [Line Items]
Number of shares purchased		18,667
Mr Conway [Member]
Related Party Transaction [Line Items]
Number of shares issued, shares			1,050	1,800					1,800
Stock based compensation									$ 1,800,000
Mr Conway [Member] | Series E Preferred Stock [Member]
Related Party Transaction [Line Items]
Preferred stock redemption price per share				$ 1,000
Stock based compensation				$ 1,800,000
Mr Conway [Member] | Series D Preferred Stock [Member]
Related Party Transaction [Line Items]
Number of shares issued, shares					1,333
Mr Conway [Member] | Employment Agreement [Member]
Related Party Transaction [Line Items]
Amount of initial annual compensation	$ 250,000
Per Month [Member] | Mr Conway [Member]
Related Party Transaction [Line Items]
Compensation value						$ 20,000		$ 20,000
Officers compensation received						$ 10,000	$ 20,000

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative)

Jan. 14, 2022$ / sharesshares

Sep. 02, 2021USD ($)

Sep. 01, 2021USD ($)

Apr. 16, 2021USD ($)

Apr. 13, 2021USD ($)

Mar. 30, 2021USD ($)$ / sharesshares

Mar. 15, 2021USD ($)shares

Feb. 26, 2021shares

Jan. 22, 2021$ / sharesshares

Jan. 14, 2021USD ($)$ / sharesshares

Jan. 06, 2021USD ($)$ / sharesshares

Jan. 02, 2021USD ($)ft²$ / sharesshares

Sep. 02, 2020USD ($)

Sep. 30, 2021USD ($)shares

Mar. 31, 2022USD ($)$ / sharesshares

Mar. 31, 2021USD ($)$ / sharesshares

Dec. 31, 2021USD ($)shares

Dec. 31, 2020USD ($)

Mar. 04, 2019USD ($)

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Cash payments

$ 25,000

Issuance of common stock | shares

637,755

Share based compensation expenses

$ 135,000

Notes payable

16,779,851

$ 13,400,730

PCTI [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Notes payable

$ 134,681

$ 151,469

Restricted Stock [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of restricted shares issued | shares

10,000,000

Shares issued, price per share | $ / shares

$ 0.0056

Share based compensation expenses

$ 56,000

PJN Strategies [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Consulting expense

$ 84,000

$ 20,000

252,000

Rubenstein Public Relations, Inc. [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Consulting expense

$ 17,000

Co-Directors of Sales [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Shares issued, price per share | $ / shares

$ 0.027

Annual salary

$ 130,000

Bonus amount

$ 20,000

Number of shares issued, shares | shares

2,500,000

Co-Directors of Sales [Member] | Restricted Stock [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Shares issued, price per share | $ / shares

$ 0.092

Number of shares issued, shares | shares

2,500,000

Share based compensation expenses

$ 460,000

Christopher Ruppel [Member] | Restricted Stock [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of restricted shares issued | shares

10,000,000

Shares issued, price per share | $ / shares

$ 0.2386

Share based compensation expenses

2,386,000

Professional fees

2,500

$ 2,500

Christopher Ruppel [Member] | Restricted Stock [Member] | April 1, 2021 [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Professional fees

$ 10,000

Ezra Green [Member] | Restricted Stock [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Shares issued, price per share | $ / shares

$ 0.0076

Consulting expense

30,000

$ 4,500

Professional fees

$ 2,500

Due to officers or stockholders

10,000

Deferred compensation equity

$ 76,000

Garage Storage Facility [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Lease term

10 years

Land subject to ground leases | ft²

2,500

Number of restricted shares issued | shares

100,000,000

Shares issued, price per share | $ / shares

$ 0.0063

Prepaid expense

$ 630,000

RMA Agreement [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of restricted shares issued | shares

452,080

Payments of stock issuance costs

$ 50,000

Number of restricted stock issued, value

$ 50,000

Payments of stock issuance costs

$ 25,000

Consulting Agreement [Member] | Restricted Stock [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of shares issued, shares | shares

20,000,000

Consulting Agreement [Member] | Mr Steven Martello [Member] | Aurora Enterprises [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of restricted shares issued | shares

5,000,000

Consulting expense

30,000

Legal fees

$ 10,000

Consulting Agreement [Member] | Mr Allen Sosis [Member] | Restricted Stock [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of restricted shares issued | shares

5,000,000

Shares issued, price per share | $ / shares

$ 0.20

Consulting expense

$ 45,000

Share based compensation expenses

1,000,000

Due to officers or stockholders

$ 15,000

Accrued employee benefits, current

1,000

Deferred compensation equity

1,000,000

Salary

$ 15,000

Consulting Agreement [Member] | Ezra Green [Member] | Restricted Stock [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of restricted shares issued | shares

10,000,000

Seperation Agreement [Member] | Salman J. Chaudhry [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Due to officers or stockholders, current

$ 227,200

Notes payable

$ 162,085

$ 162,085

Exchange Agreement [Member] | PCTI [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Shares issued, price per share | $ / shares

$ 0.094

$ 0.094

Professional fees

$ 750,000

Collaborative arrangement, rights and obligations

PCTI agreed to pay the third-party a perpetual three percent (3%) payment of revenues, as defined in the agreement.

Number of common stock exchanged | shares

175,000,000

Royalty percentage

1.80%

Payments of debt restructuring costs

$ 16,450,000

STOCKHOLDERS_ EQUITY (Details N

STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)

Jul. 13, 2021

Apr. 16, 2021

Mar. 24, 2021

Mar. 21, 2021

Mar. 02, 2021

Aug. 28, 2020

Jul. 10, 2020

Jul. 10, 2020

Jul. 07, 2020

Jul. 28, 2021

Mar. 31, 2022

Mar. 31, 2021

Dec. 31, 2021

Jul. 27, 2021

Dec. 31, 2020

Class of Stock [Line Items]

Debt instrument principal

$ 760,500

Debt instrument, accrued interest

$ 116,594

Debt conversion, converted instrument, shares issued

428,747,654

Debt instrument, convertible, conversion price

$ 0.002

Purchase of warrants

330,797,987

Common Stock, Shares Authorized

4,990,000,000

4,990,000,000

Common Stock, Par or Stated Value Per Share

$ 0.001

$ 0.001

Common Stock, Shares, Outstanding

4,622,362,977

4,617,362,977

Preferred stock, shares authorized

10,000,000

10,000,000

Preferred stock, price per share

$ 0.001

$ 0.001

Share-based payment arrangement, expense

$ 135,000

Mr Conway [Member]

Class of Stock [Line Items]

Number of shares issued, shares

1,050

1,800

1,800

Share-based payment arrangement, expense

$ 1,800,000

Series C Preferred Stock [Member]

Class of Stock [Line Items]

Preferred stock, shares authorized

50,000

50,000

Preferred stock, price per share

$ 0.001

$ 0.001

Preferred stock shares outstanding

2,500

2,500

50,000

Preferred stock shares issued

2,500

2,500

Series C Preferred Stock [Member] | Mr Conway [Member]

Class of Stock [Line Items]

Preferred stock, shares

2,500

Series C Preferred Stock [Member] | Chis [Member]

Class of Stock [Line Items]

Number of purchased shares

47,500

Series D Preferred Stock [Member]

Class of Stock [Line Items]

Purchase of warrants

3,236

3,236

Preferred stock, shares authorized

4,570

4,570

Preferred stock, price per share

$ 0.001

$ 0.001

Preferred stock shares outstanding

1,334

1,334

Preferred stock shares issued

1,334

1,334

Series D Preferred Stock [Member] | Mr Conway [Member]

Class of Stock [Line Items]

Number of shares issued, shares

1,333

Series D Preferred Stock [Member] | Chis [Member]

Class of Stock [Line Items]

Number of purchased shares

18,667

Series E Preferred Stock [Member]

Class of Stock [Line Items]

Number of shares issued, shares

2,000

Preferred stock, shares authorized

2,000

3,000

3,000

Preferred stock, price per share

$ 0.001

$ 0.001

Preferred stock shares outstanding

0

0

Preferred stock shares issued

0

0

Number of stock redeemed

3,000

Series E Preferred Stock [Member] | Mr. Convay [Member]

Class of Stock [Line Items]

Number of shares issued, shares

1,800

Preferred stock, redemption price per share

$ 1,000

Share-based payment arrangement, expense

$ 2,000,000

Series E Preferred Stock [Member] | Third-Party [Member]

Class of Stock [Line Items]

Number of shares issued, shares

200

Series E Preferred Stock [Member] | Mr Conway [Member]

Class of Stock [Line Items]

Preferred stock, redemption price per share

$ 1,000

Share-based payment arrangement, expense

$ 1,800,000

Series E Preferred Stock [Member] | Chis [Member]

Class of Stock [Line Items]

Number of shares issued, shares

500

Restructuring Agreement [Member]

Class of Stock [Line Items]

Deferred compensation shares issued

175,000,000

Certificates of Designation [Member] | Series C Preferred Stock [Member]

Class of Stock [Line Items]

Preferred stock, shares authorized

50,000

Preferred stock, voting rights

The holders of Series C Preferred Stock have no conversion rights and no dividend rights. For so long as any shares of the Series C Preferred Stock remain issued and outstanding, the Holder thereof, voting separately as a class, shall have the right to vote on all shareholder matters equal to sixty-seven (67%) percent of the total vote.

Certificates of Designation [Member] | Series D Preferred Stock [Member]

Class of Stock [Line Items]

Preferred stock, shares authorized

20,000

Certificates of Designation [Member] | Series E Preferred Stock [Member]

Class of Stock [Line Items]

Preferred stock, shares authorized

3,000

Preferred stock, redemption amount

$ 1,000

Securities Purchase Agreement [Member] | Series C Preferred Stock [Member] | PCTI [Member]

Class of Stock [Line Items]

Number of shares issued, shares

47,500

Securities Purchase Agreement [Member] | Series D Preferred Stock [Member] | PCTI [Member]

Class of Stock [Line Items]

Number of shares issued, shares

18,667

Series D Amendment [Member] | Series D Preferred Stock [Member]

Class of Stock [Line Items]

Preferred stock, shares authorized

4,570

Preferred Stock, Convertible, Conversion Price

$ 1.5

Series DSPA [Member] | Series D Preferred Stock [Member] | Investor [Member]

Class of Stock [Line Items]

Purchase of warrants

3,236

Proceeds from Issuance of Preferred Stock and Preference Stock

$ 13,200,000

Employment Agreement [Member] | Series E Preferred Stock [Member] | Conway [Member]

Class of Stock [Line Items]

Number of shares issued, shares

500

Restricted Stock [Member]

Class of Stock [Line Items]

Share-based payment arrangement, expense

$ 56,000

Restricted Stock [Member] | Lease Agreement [Member]

Class of Stock [Line Items]

Number of shares issued, shares

5,000,000

100,000,000

Restricted Stock [Member] | Consulting Agreement [Member]

Class of Stock [Line Items]

Number of shares issued, shares

20,000,000

Warrant [Member]

Class of Stock [Line Items]

Warrants term

15 years

Warrant exercise

162

Warrant exercise, description

During every 1(one) year period, starting on the day that is the Lock Up Period Termination Date, the Holder shall have the right to exercise the Remainder of the Warrant up to a maximum number of Remaining Warrant Shares that, if converted, would be equal to no more than a maximum of 4.99% of the total number of outstanding shares of Common Stock of the Company during such given year (“Leak-Out Period”). The Leak-Out Period shall come into effect on the day that is the Lock Up Period Termination Date and remain effective on a yearly basis, for a period of 10 (ten) years thereafter, after which the Leak-Out Period will automatically terminate and become null and void. For clarity purposes the Remainder of the Warrant shall become freely exercisable at any time or times beginning on June 29, 2034 and until the Termination Date.

Remaining Warrant Shares [Member]

Class of Stock [Line Items]

Warrant exercise

3,074

NONCONTROLLING INTEREST (Detail

NONCONTROLLING INTEREST (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Aug. 19, 2021
Noncontrolling interest loss	$ 383,077
Noncontrolling interest	187,708
Accumulative noncontrolling interest	$ 422,813
Brian Conway [Member]
Noncontrolling interest percentage			51.00%
PJN Strategies [Member]
Noncontrolling interest percentage			49.00%

SCHEDULE OF RIGHT-OF-USE ASSETS

SCHEDULE OF RIGHT-OF-USE ASSETS (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Operating Lease Right-of-use Assets And Operating Lease Liabilities
Office and warehouse lease	$ 888,026
Less: Accumulated Amortization	(230,687)
Right-of-use asset, net	$ 657,339	$ 707,686

SCHEDULE OF OPERATING LEASE LIA

SCHEDULE OF OPERATING LEASE LIABILITIES (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Operating Lease Right-of-use Assets And Operating Lease Liabilities
Lease liability	$ 663,866
Less current portion	(177,858)	$ (194,366)
Long term portion	$ 486,008	$ 517,890

SCHEDULE OF MATURITY OF LEASE L

SCHEDULE OF MATURITY OF LEASE LIABILITIES (Details)	Mar. 31, 2022USD ($)
Operating Lease Right-of-use Assets And Operating Lease Liabilities
For the year ended December 31, 2022	$ 179,548
For the year ended December 31, 2023	167,858
For the year ended December 31, 2024	171,840
For the year ended December 31, 2025	175,942
For the year ended December 31, 2026	74,030
Total	769,218
Less present value discount	(105,352)
Lease liability	$ 663,866

OPERATING LEASE RIGHT-OF-USE _3

OPERATING LEASE RIGHT-OF-USE ASSETS AND OPERATING LEASE LIABILITIES (Details Narrative)	Apr. 14, 2021USD ($)ft²	Mar. 31, 2022USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2021USD ($)
Lease expiration date		Nov. 30, 2022
Operating lease disount rate		7.50%
Operating lease rent expense			$ 84,278
Operating lease liability		$ 663,866
RIght of use of asset		$ 657,339		$ 707,686
Operating lease term	5 years
Area of land | ft²	8,100
Thereafter [Member]
Lease payments increase percentage	2.40%
CANADA
Lease expiration date	May 31, 2026
Operating lease payments	$ 13,148
Lease payments increase percentage	7.50%
Accounting Standards Update 2016-02 [Member]
Operating lease liability			185,139	702,888
RIght of use of asset			$ 185,139	$ 702,888

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - shares	Apr. 04, 2022	Mar. 15, 2021
Subsequent Event [Line Items]
Common stock maturity period		Dec. 26, 2021
Common Stock [Member] | Subsequent Event [Member] | Securities Purchase Agreement [Member] | GHS Investments [Member]
Subsequent Event [Line Items]
Number of shares issued, shares	200,000,000
Common stock maturity period	Oct. 4, 2022